Skip to main content

Table 2 Description of the treatment in the included studies

From: Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis

Study

Model*

Treatment duration (months)

Drugs in regimen†

DOTS location

DOTS provider

Additional community involvement

Drobac et al. [19]

I

18-24

n/a

Local health centre

CHWs, nurses

CHWs provided doses outside centre hours

Joseph et al. [17]

S

6-9, 18

6,4

Local health centre

HCWs, friends/neighbours

Health education provided for family

Malla et al. [22]

S

8-12,16-24

5,4

Decentralized clinics

Health workers

Nominated treatment support person required

Mitnick et al. [20]

I

Median 23 (0 · 4-35 · 9)

Median 6 (5-9)

Outpatient

CHWs, nurses

-

Mitnick et al. [21]

I

≥18

≥5

Health centre or patient home

CHWs

Group therapy as needed

Oyieng’o et al. [24]

S

≥6, 18

5,4

Local health centre or patient home

Local nurse, HCW, household member

Household member supervised evening dose

Satti et al. [25]

I

≥18

6

Outpatient

CHWs

Community team tracked patients and provided support

Singla et al. [16]

S

6-9, 18

5,3

Peripheral health centre or patient home

HCW, household member

Household member supervised evening dose

Thomas et al. [18]

I

≥18

5, ≥2

Village health centres, clinics or hospital

Anganwadi workers, village HCWs, private practitioners

-

Tupasi et al. [26]

I

≥6, ≥18

5, 4

Local health centre, or patient home

HCWs

Treatment partner nominated by the patient

  1. *I = Individualized, S = Standardized.
  2. ‡Duration of intensive phase and continuation phase are separated by a comma. Otherwise duration represents length of treatment. †Number of drugs in intensive and continuation regimens separated by a comma.